SkinTE by RegenETP for Diabetic Foot Ulcers: Likelihood of Approval

SkinTE is under clinical development by RegenETP and currently in Phase III for Diabetic Foot Ulcers.

Researchers uncover hidden roles of accessory genes in SARS-CoV-2

Viruses are lean, mean, infection machines. Their genomes are tiny, usually limited to a handful of absolutely essential genes, and they shed extra genomic deadweight

November 20, 2024

Scientists take a (small) step toward universal antivenom

Antivenom, like Mexican Coke or grandma’s cookies, is still made the old-fashioned way. In antivenom’s case, the recipe is straightforward: Pump a horse full of

February 21, 2024

New compound shows promise as a more effective treatment for schistosomiasis

A newly developed compound is showing promise in animal studies as a more effective treatment for human schistosomiasis, an understudied tropical disease caused by parasitic

March 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.